POSITION
Lead Investor
BOARD
Member
Phenomic AI leverages computer vision and high-content screening to develop therapeutic antibodies against cancer and fibrosis. The company screens and develops their own therapeutic antibodies against these disease models with the goal of bringing ground-breaking drugs to the clinic for diseases like colorectal cancer. CTI Life Sciences Fund led the financing round for Phenomic AI in June 2020.